Skip to Content

APRESAZIDE 25/25 CIBA 139 (Apresazide 25 mg / 25 mg)

Generic Name: hydralazine/hydrochlorothiazide

This pill with imprint "APRESAZIDE 25/25 CIBA 139" is Blue / White, Capsule-shape and has been identified as Apresazide 25 mg / 25 mg. It is supplied by Novartis Pharmaceuticals.

Apresazide is used in the treatment of heart failure; high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Apresazide 25 mg / 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for APRESAZIDE 25/25 CIBA 139

Apresazide

Generic Name:
hydralazine/hydrochlorothiazide
Imprint:
APRESAZIDE 25/25 CIBA 139
Strength:
25 mg / 25 mg
Color:
Blue / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antihypertensive combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
National Drug Code (NDC):
00083-0139

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide